1	Interleukin-7	Interleukin-7	_	_	_	_	_	_	_
2	upregulates	upregulate	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	interleukin-2-gene	interleukin-2-gene	_	_	_	_	_	_	_
5	expression	expression	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	activated	activate	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	T	t	_	_	_	_	_	_	_
10	lymphocytes	lymphocyte	_	_	_	_	_	_	_
11	at	at	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	transcriptional	transcriptional	_	_	_	_	_	_	_
14	level	level	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	enhancing	enhance	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	DNA	dna	_	_	_	_	_	_	_
19	binding	binding	_	_	_	_	_	_	_
20	activities	activity	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	both	both	_	_	_	_	_	_	_
23	nuclear	nuclear	_	_	_	_	_	_	_
24	factor	factor	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	activated	activate	_	_	_	_	_	_	_
27	T	t	_	_	_	_	_	_	_
28	cells	cell	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	activator	activator	_	_	_	_	_	_	_
31	protein-1	protein-1	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	present	present	_	_	_	_	_	_	_
4	report	report	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	we	we	_	_	_	_	_	_	_
7	studied	study	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	role	role	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	stromal-derived	stromal-derived	_	_	_	_	_	_	_
13	cytokine	cytokine	_	_	_	_	_	_	_
14	interleukin-7	interleukin-7	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	IL-7	il-7	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	IL-2-gene	il-2-gene	_	_	_	_	_	_	_
21	regulation	regulation	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	activated	activate	_	_	_	_	_	_	_
24	T	t	_	_	_	_	_	_	_
25	lymphocytes	lymphocyte	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Production	production	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	IL-2	il-2	_	_	_	_	_	_	_
4	requires	require	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	formation	formation	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	transcription	transcription	_	_	_	_	_	_	_
9	factors	factor	_	_	_	_	_	_	_
10	involved	involve	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	IL-2-gene	il-2-gene	_	_	_	_	_	_	_
14	regulation	regulation	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	T-cell	t-cell	_	_	_	_	_	_	_
2	receptor	receptor	_	_	_	_	_	_	_
3	(	(	_	_	_	_	_	_	_
4	TCR)/CD3	tcr)/cd3	_	_	_	_	_	_	_
5	engagement	engagement	_	_	_	_	_	_	_
6	results	result	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	nuclear	nuclear	_	_	_	_	_	_	_
12	factor	factor	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	activated	activate	_	_	_	_	_	_	_
15	T	t	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	NFAT	NFAT	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	activator	activator	_	_	_	_	_	_	_
22	protein-1	protein-1	_	_	_	_	_	_	_
23	(	(	_	_	_	_	_	_	_
24	AP-1	ap-1	_	_	_	_	_	_	_
25	)	)	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	nuclear	nuclear	_	_	_	_	_	_	_
29	factor	factor	_	_	_	_	_	_	_
30	kappaB	kappaB	_	_	_	_	_	_	_
31	(	(	_	_	_	_	_	_	_
32	NFkappaB	NFkappaB	_	_	_	_	_	_	_
33	)	)	_	_	_	_	_	_	_
34	,	,	_	_	_	_	_	_	_
35	whereas	whereas	_	_	_	_	_	_	_
36	the	the	_	_	_	_	_	_	_
37	CD28	cd28	_	_	_	_	_	_	_
38	responsive	responsive	_	_	_	_	_	_	_
39	complex	complex	_	_	_	_	_	_	_
40	(	(	_	_	_	_	_	_	_
41	CD28RC	CD28RC	_	_	_	_	_	_	_
42	)	)	_	_	_	_	_	_	_
43	is	be	_	_	_	_	_	_	_
44	activated	activate	_	_	_	_	_	_	_
45	in	in	_	_	_	_	_	_	_
46	response	response	_	_	_	_	_	_	_
47	to	to	_	_	_	_	_	_	_
48	the	the	_	_	_	_	_	_	_
49	CD28	cd28	_	_	_	_	_	_	_
50	signal	signal	_	_	_	_	_	_	_
51	.	.	_	_	_	_	_	_	_

1	Costimulation	costimulation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	phytohemagglutinin/anti-CD28	phytohemagglutinin/anti-cd28	_	_	_	_	_	_	_
4	activated	activate	_	_	_	_	_	_	_
5	T	t	_	_	_	_	_	_	_
6	lymphocytes	lymphocyte	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	IL-7	IL-7	_	_	_	_	_	_	_
9	induces	induce	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	fivefold	fivefold	_	_	_	_	_	_	_
12	enhanced	enhance	_	_	_	_	_	_	_
13	IL-2-mRNA	IL-2-mRNA	_	_	_	_	_	_	_
14	accumulation	accumulation	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	2.5-fold	2.5-fold	_	_	_	_	_	_	_
18	enhanced	enhance	_	_	_	_	_	_	_
19	protein	protein	_	_	_	_	_	_	_
20	secretion	secretion	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	IL-2-gene	il-2-gene	_	_	_	_	_	_	_
3	transcription	transcription	_	_	_	_	_	_	_
4	rate	rate	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	increased	increase	_	_	_	_	_	_	_
7	3.4-fold	3.4-fold	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	indicating	indicate	_	_	_	_	_	_	_
10	that	that	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	effect	effect	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	IL-7	IL-7	_	_	_	_	_	_	_
15	is	be	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	part	part	_	_	_	_	_	_	_
18	mediated	mediate	_	_	_	_	_	_	_
19	at	at	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	transcriptional	transcriptional	_	_	_	_	_	_	_
22	level	level	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	molecular	molecular	_	_	_	_	_	_	_
3	mechanisms	mechanism	_	_	_	_	_	_	_
4	underlying	underlie	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	IL-7	il-7	_	_	_	_	_	_	_
7	effect	effect	_	_	_	_	_	_	_
8	involve	involve	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	upregulation	upregulation	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	DNA	dna	_	_	_	_	_	_	_
14	binding	binding	_	_	_	_	_	_	_
15	activity	activity	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	NFAT	NFAT	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	60	60	_	_	_	_	_	_	_
20	%	%	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	AP-1	ap-1	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	120	120	_	_	_	_	_	_	_
26	%	%	_	_	_	_	_	_	_
27	)	)	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	without	without	_	_	_	_	_	_	_
30	affecting	affect	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	activities	activity	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	NFkappaB	NFkappaB	_	_	_	_	_	_	_
35	and	and	_	_	_	_	_	_	_
36	CD28RC	CD28RC	_	_	_	_	_	_	_
37	,	,	_	_	_	_	_	_	_
38	which	which	_	_	_	_	_	_	_
39	was	be	_	_	_	_	_	_	_
40	confirmed	confirm	_	_	_	_	_	_	_
41	by	by	_	_	_	_	_	_	_
42	transfection	transfection	_	_	_	_	_	_	_
43	assays	assay	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	also	also	_	_	_	_	_	_	_
3	show	show	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	IL-7-induced	il-7-induced	_	_	_	_	_	_	_
7	enhancement	enhancement	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	AP-1-DNA	AP-1-DNA	_	_	_	_	_	_	_
11	binding	binding	_	_	_	_	_	_	_
12	activity	activity	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	not	not	_	_	_	_	_	_	_
15	cyclosporin	cyclosporin	_	_	_	_	_	_	_
16	A-sensitive	a-sensitive	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Since	since	_	_	_	_	_	_	_
2	AP-1	ap-1	_	_	_	_	_	_	_
3	is	be	_	_	_	_	_	_	_
4	part	part	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	NFAT	NFAT	_	_	_	_	_	_	_
8	complex	complex	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	we	we	_	_	_	_	_	_	_
11	conclude	conclude	_	_	_	_	_	_	_
12	that	that	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	IL-7-signaling	il-7-signaling	_	_	_	_	_	_	_
15	pathway	pathway	_	_	_	_	_	_	_
16	is	be	_	_	_	_	_	_	_
17	involved	involve	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	activation	activation	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	fos	fos	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	jun	jun	_	_	_	_	_	_	_
26	proteins	protein	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	which	which	_	_	_	_	_	_	_
29	AP-1	ap-1	_	_	_	_	_	_	_
30	consists	consist	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

